Veeva Systems Inc. $VEEV Shares Sold by Swiss National Bank

Swiss National Bank lowered its holdings in Veeva Systems Inc. (NYSE:VEEV) by 4.4% in the third quarter, Holdings Channel.com reports. The firm owned 447,500 shares of the technology company’s stock after selling 20,400 shares during the period. Swiss National Bank’s holdings in Veeva Systems were worth $133,315,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in VEEV. GPS Wealth Strategies Group LLC boosted its stake in Veeva Systems by 196.4% in the 3rd quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock worth $25,000 after buying an additional 55 shares during the last quarter. Raiffeisen Bank International AG acquired a new position in shares of Veeva Systems during the 3rd quarter valued at about $28,000. OLD Second National Bank of Aurora purchased a new position in shares of Veeva Systems during the 3rd quarter worth about $30,000. Cary Street Partners Investment Advisory LLC boosted its position in shares of Veeva Systems by 58.3% in the second quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after acquiring an additional 49 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Veeva Systems in the second quarter worth approximately $41,000. 88.20% of the stock is currently owned by institutional investors and hedge funds.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced the acquisition of Ostro, an AI‑driven brand engagement/chat platform for life sciences — a strategic bolt‑on to improve patient/physician engagement and add AI chat capabilities that can be cross‑sold into Veeva’s Commercial and Data Clouds; deal reported at ~$100M, signaling targeted M&A to accelerate growth. Veeva Systems Acquires Ostro for $100M
• Positive Sentiment: AOP Health is standardizing on the Veeva Industry Cloud across R&D, quality, commercial, and data — a notable customer win that supports recurring revenue and platform stickiness as Veeva ties development, quality and commercialization workflows for an international rare‑disease specialist. AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
• Neutral Sentiment: Analysts and commentators note Veeva’s broader market positioning (including potential to support index/ETF performance), but these narratives are longer‑term and less likely to move the stock intraday compared with corporate actions and analyst revisions. Veeva Systems Success Could Support Russell 1000 ETF Performance Ahead
• Neutral Sentiment: Technical backdrop is unfavorable: price is below the 50‑day ($202.20) and 200‑day ($245.59) moving averages, which can exacerbate downside pressure while investors digest news and analyst revisions.
• Negative Sentiment: Citigroup lowered its VEEV price target from $319 to $291 while retaining a Buy rating — a material cut to upside expectations that can sap near‑term sentiment despite the firm still seeing significant upside vs. the current share price. Citigroup Has Lowered Expectations for Veeva Systems (NYSE:VEEV) Stock Price

Veeva Systems Trading Down 2.9%

Shares of NYSE VEEV opened at $189.83 on Wednesday. The stock has a fifty day moving average price of $202.20 and a 200 day moving average price of $245.59. Veeva Systems Inc. has a 12-month low of $168.13 and a 12-month high of $310.50. The company has a market cap of $31.21 billion, a P/E ratio of 35.09, a P/E/G ratio of 1.35 and a beta of 1.09.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $835.95 million during the quarter, compared to the consensus estimate of $810.95 million. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The company’s revenue was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, sell-side analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Veeva Systems declared that its board has authorized a share repurchase plan on Monday, January 5th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the technology company to purchase up to 5.5% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

A number of equities analysts have weighed in on VEEV shares. Jefferies Financial Group reaffirmed a “buy” rating and set a $330.00 price target on shares of Veeva Systems in a research note on Monday, November 24th. Weiss Ratings lowered Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Piper Sandler lowered their price target on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Canaccord Genuity Group cut their price objective on Veeva Systems from $280.00 to $235.00 and set a “hold” rating on the stock in a report on Thursday, March 5th. Finally, UBS Group boosted their target price on Veeva Systems from $200.00 to $220.00 and gave the stock a “neutral” rating in a report on Thursday, March 5th. Seventeen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $283.70.

Insider Activity at Veeva Systems

In other news, insider Thomas D. Schwenger sold 1,000 shares of the company’s stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total value of $231,430.00. Following the completion of the transaction, the insider directly owned 23,204 shares in the company, valued at approximately $5,370,101.72. This represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 10.30% of the company’s stock.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.